Naresh Kanumilli

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management.

Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: March 30, 2026

Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus.

Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus.

Journal: Advances in therapy

Published: March 09, 2026

Annual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of tirzepatide versus subcutaneous semaglutide 1 mg in patients with type 2 diabetes in the UK.

Annual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of tirzepatide versus subcutaneous semaglutide 1 mg in patients with type 2 diabetes in the UK.

Journal: Journal of medical economics

Published: March 02, 2026

Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature Review.

Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature Review.

Journal: Advances in therapy

Published: December 18, 2025

Study protocol for an open-label, single-arm, mixed methods feasibility study of the MWIQ AI-powered decision support tool for diabetes management in GP practices.

Study protocol for an open-label, single-arm, mixed methods feasibility study of the MWIQ AI-powered decision support tool for diabetes management in GP practices.

Journal: BMJ open

Published: October 05, 2025

Empowering Heart Failure Patients: The Role, Importance, and Considerations of Active Patient Engagement in Improving Delivery of Guideline-Directed Medical Therapy.

Empowering Heart Failure Patients: The Role, Importance, and Considerations of Active Patient Engagement in Improving Delivery of Guideline-Directed Medical Therapy.

Journal: Journal of patient experience

Published: September 29, 2025

Clinical and cost-effectiveness of the digital intervention, MyWay Diabetes, in people with type 2 diabetes living in Greater Manchester during the COVID-19 pandemic.

Clinical and cost-effectiveness of the digital intervention, MyWay Diabetes, in people with type 2 diabetes living in Greater Manchester during the COVID-19 pandemic.

Journal: PloS one

Published: August 13, 2025

Association of British Clinical Diabetologists and UK Kidney Association Joint Clinical Practice Guidelines for the Pharmacological Management of Hyperglycemia in Adults With Type 2 Diabetes Mellitus and CKD.

Association of British Clinical Diabetologists and UK Kidney Association Joint Clinical Practice Guidelines for the Pharmacological Management of Hyperglycemia in Adults With Type 2 Diabetes Mellitus and CKD.

Journal: Kidney international reports

Published: April 21, 2025

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes.

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes.

Journal: Cardiovascular diabetology

Published: February 18, 2025

Research recommendations from the 2024 Breakthrough T1D, Diabetes UK and Kidney Research UK, diabetes and kidney disease expert workshop.

Research recommendations from the 2024 Breakthrough T1D, Diabetes UK and Kidney Research UK, diabetes and kidney disease expert workshop.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: December 12, 2024

Highlighting the new consensus guidelines for managing people at risk of, and with early-stage type 1 diabetes-Relevance to clinical care in the UK.

Highlighting the new consensus guidelines for managing people at risk of, and with early-stage type 1 diabetes-Relevance to clinical care in the UK.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: October 03, 2024

Current management of chronic kidney disease in type-2 diabetes-A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) guidelines.

Current management of chronic kidney disease in type-2 diabetes-A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) guidelines.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: July 31, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026